ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003

Senate Democrats Include $1 Billion Boost To NIH In Economic Stimulus Package.

November 21, 2008

Page 2: The Debate Over Brigham’s Containment Bag Study

November 21, 2014

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986

Final Issue Of the Year

December 14, 1990